CYP27A1-dependent anti-melanoma activity of limonoid natural products targets mitochondrial metabolism
Hyelim Cho,Qiong Shen,Lydia H Zhang,Mikiko Okumura,Akinori Kawakami,Jessi Ambrose,Frederic Sigoillot,Howard R Miller,Scott Gleim,Amanda Cobos-Correa,Ying Wang,Philippe Piechon,Guglielmo Roma,Fabian Eggimann,Charles Moore,Peter Aspesi,Felipa A Mapa,Heather Burks,Nathan T Ross,Philipp Krastel,Marc Hild,Thomas J Maimone,David E Fisher,Daniel K Nomura,John A Tallarico,Stephen M Canham,Jeremy L Jenkins,William C Forrester,Lydia H. Zhang,Howard R. Miller,Felipa A. Mapa,Nathan T. Ross,Thomas J. Maimone,David E. Fisher,Daniel K. Nomura,John A. Tallarico,Stephen M. Canham,Jeremy L. Jenkins,William C. Forrester
DOI: https://doi.org/10.1016/j.chembiol.2021.03.004
IF: 9.039
2021-10-01
Cell Chemical Biology
Abstract:<h2 class="section-title u-h3 u-margin-l-top u-margin-xs-bottom">Summary</h2><p>Three limonoid natural products with selective anti-proliferative activity against BRAF(V600E) and NRAS(Q61K)-mutation-dependent melanoma cell lines were identified. Differential transcriptome analysis revealed dependency of compound activity on expression of the mitochondrial cytochrome P450 oxidase <em>CYP27A1</em>, a transcriptional target of melanogenesis-associated transcription factor (MITF). We determined that CYP27A1 activity is necessary for the generation of a reactive metabolite that proceeds to inhibit cellular proliferation. A genome-wide small interfering RNA screen in combination with chemical proteomics experiments revealed gene-drug functional epistasis, suggesting that these compounds target mitochondrial biogenesis and inhibit tumor bioenergetics through a covalent mechanism. Our work suggests a strategy for melanoma-specific targeting by exploiting the expression of MITF target gene <em>CYP27A1</em> and inhibiting mitochondrial oxidative phosphorylation in BRAF mutant melanomas.</p>
biochemistry & molecular biology